BERTANI, LORENZO Statistiche
BERTANI, LORENZO
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients
In corso di stampa Bertani, L; Tricò, D; Pugliese, D; Privitera, G; Linsalata, G; Zanzi, F; Mumolo, Mg; Barberio, B; Monzani, F; Marchi, S; Guidi, L; Blandizzi, C; Armuzzi, A; Costa, F
Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapy
2024-01-01 Bertani, L; Tricò, D; Barberio, B; Vernero, M; Bretto, E; Ceccarelli, L; Pardi, V; Calabrese, F; Pasta, A; Bertin, L; Fabiana, Z; Semprucci, G; Bodini, G; Ribaldone, D G; Savarino, E V; Costa, F
P965 Ulcerative proctitis treated with biologics: is it too hard to treat?
2024-01-01 Bertani, L; Tricò, D; Barberio, B; Bretto, E; Ceccarelli, L; Calabrese, F; Pasta, A; Bertin, L; Fabiana, Z; Maniero, D; Frara, S; De Bernardi, A; Bodini, G; Ribaldone, D G; Costa, F; Savarino, E V
Ulcerative proctitis treated with biologics: is it too hard to treat?
2024-01-01 Bertani, L.; Trico, D.; Barberio, B.; Bretto, E.; Ceccarelli, L.; Calabrese, F.; Pasta, A.; Bertin, L.; Fabiana, Z.; Maniero, D.; Frara, S.; De Bernardi, A.; Bodini, G.; Ribaldone, D. G.; Costa, F.; Savarino, E. V.
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics
2023-01-01 Guglielmi, Giorgio; Crucitta, Stefania; Bertani, Lorenzo; Ruglioni, Martina; Svizzero, Giovanni Baiano; Ceccarelli, Linda; Del Re, Marzia; Danesi, Romano; Costa, Francesco; Fogli, Stefano
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use
2023-01-01 Ferraro, Sara; Cappello, Emiliano; Bartolini, Claudia; Convertino, Irma; Bertani, Lorenzo; Lucenteforte, Ersilia; Costa, Francesco; Paoletti, Olga; Giometto, Sabrina; Gini, Rosa; Tuccori, Marco
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis
2022-01-01 D'Antongiovanni, Vanessa; Pellegrini, Carolina; Benvenuti, Laura; Fornai, Matteo; Di Salvo, Clelia; Natale, Gianfranco; Ryskalin, Larisa; Bertani, Lorenzo; Lucarini, Elena; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Nemeth, Zoltan H; Haskó, György; Antonioli, Luca
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue
2022-01-01 Bertani, Lorenzo; Tricò, Domenico
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry
2022-01-01 Tapete, Gherardo; Bertani, Lorenzo; Pieraccini, Alberto; Lynch, Erica Nicola; Giannotta, Martina; Morganti, Riccardo; Biviano, Ivano; Naldini, Sara; Mumolo, Maria Gloria; De Nigris, Francesca; Calella, Francesca; Bagnoli, Siro; Minciotti, Moira; Maltinti, Simona; Rentini, Silvia; Ceccarelli, Linda; Lionetti, Paolo; Milla, Monica; Costa, Francesco
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease
2022-01-01 Bellini, G.; Benvenuti, L.; Ippolito, C.; Frosini, D.; Segnani, C.; Rettura, F.; Pancetti, A.; Bertani, L.; D'Antongiovanni, V.; Palermo, G.; Del Prete, E.; Antonioli, L.; Nardini, V.; Morganti, R.; Pellegrini, C.; Bernardini, N.; Ceravolo, R.; Fornai, M.; Bellini, M.
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease
2022-01-01 Bellini, Gabriele; Benvenuti, Laura; Ippolito, Chiara; Frosini, Daniela; Segnani, Cristina; Rettura, Francesco; Pancetti, Andrea; Bertani, Lorenzo; D'Antongiovanni, Vanessa; Palermo, Giovanni; Del Prete, Eleonora; Antonioli, Luca; Nardini, Vincenzo; Morganti, Riccardo; Pellegrini, Carolina; Bernardini, Nunzia; Ceravolo, Roberto; Fornai, Matteo; Bellini, Massimo
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study
2021-01-01 Barberio, B.; Cingolani, L.; Canova, C.; Barbieri, G.; Sablich, R.; Urbano, M. T.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Ferronato, A.; Buda, A.; Melatti, P.; Massimi, D.; Savarino, E. V.; Zingone, F.
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
2021-01-01 Cingolani, L.; Barberio, B.; Zingone, F.; Ferronato, A.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Melatti, P.; Gubbiotti, A.; Massimi, D.; Casadei, C.; D'Inca, R.; Savarino, E. V.
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy)
2021-01-01 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy
2021-01-01 Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults
2021-01-01 Visaggi, P.; Savarino, E.; Sciume, G.; Chio, T. D.; Bronzini, F.; Tolone, S.; Frazzoni, M.; Pugno, C.; Ghisa, M.; Bertani, L.; Bellini, M.; Savarino, V.; Peroni, D.; Marchi, S.; de Bortoli, N.
Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak
2021-01-01 Bertani, Lorenzo; Barberio, Brigida; Tricò, Domenico; Zanzi, Federico; Maniero, Daria; Ceccarelli, Linda; Marsilio, Ilaria; Coppini, Francesca; Lorenzon, Greta; Mumolo, Maria Gloria; Zingone, Fabiana; Costa, Francesco; Savarino, Edoardo Vincenzo
HOSPITALIZATION FOR DRUG INFUSION DOES NOT INCREASE COVID INFECTION RATE, IBD RELAPSES DUE TO INFECTIONS AND LEVELS OF ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY
2021-01-01 Bertani, L; Barberio, B; Trico, D; Zanzi, F; Maniero, D; Ceccarelli, L; Marsilio, I; Minciotti, M; Coppini, F; Lorenzon, G; Mumolo, Mg; Zingone, F; Costa, F; Savarino, Ev
Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers
2021-01-01 Capecchi, R.; Migliorini, P.; Zanzi, F.; Maltinti, S.; Puxeddu, I.; de Bortoli, N.; Bellini, M.; Costa, F.; Marchi, S.; Bertani, L.
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis
2021-01-01 Bertani, L.; Trico, D.; Zanzi, F.; Svizzero, G. B.; Coppini, F.; de Bortoli, N.; Bellini, M.; Antonioli, L.; Blandizzi, C.; Marchi, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients | In corso di stampa | Bertani, L; Tricò, D; Pugliese, D; Privitera, G; Linsalata, G; Zanzi, F; Mumolo, Mg; Barberio, B; Monzani, F; Marchi, S; Guidi, L; Blandizzi, C; Armuzzi, A; Costa, F | |
| Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapy | 1-gen-2024 | Bertani, L; Tricò, D; Barberio, B; Vernero, M; Bretto, E; Ceccarelli, L; Pardi, V; Calabrese, F; Pasta, A; Bertin, L; Fabiana, Z; Semprucci, G; Bodini, G; Ribaldone, D G; Savarino, E V; Costa, F | |
| P965 Ulcerative proctitis treated with biologics: is it too hard to treat? | 1-gen-2024 | Bertani, L; Tricò, D; Barberio, B; Bretto, E; Ceccarelli, L; Calabrese, F; Pasta, A; Bertin, L; Fabiana, Z; Maniero, D; Frara, S; De Bernardi, A; Bodini, G; Ribaldone, D G; Costa, F; Savarino, E V | |
| Ulcerative proctitis treated with biologics: is it too hard to treat? | 1-gen-2024 | Bertani, L.; Trico, D.; Barberio, B.; Bretto, E.; Ceccarelli, L.; Calabrese, F.; Pasta, A.; Bertin, L.; Fabiana, Z.; Maniero, D.; Frara, S.; De Bernardi, A.; Bodini, G.; Ribaldone, D. G.; Costa, F.; Savarino, E. V. | |
| Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics | 1-gen-2023 | Guglielmi, Giorgio; Crucitta, Stefania; Bertani, Lorenzo; Ruglioni, Martina; Svizzero, Giovanni Baiano; Ceccarelli, Linda; Del Re, Marzia; Danesi, Romano; Costa, Francesco; Fogli, Stefano | |
| Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use | 1-gen-2023 | Ferraro, Sara; Cappello, Emiliano; Bartolini, Claudia; Convertino, Irma; Bertani, Lorenzo; Lucenteforte, Ersilia; Costa, Francesco; Paoletti, Olga; Giometto, Sabrina; Gini, Rosa; Tuccori, Marco | |
| Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis | 1-gen-2022 | D'Antongiovanni, Vanessa; Pellegrini, Carolina; Benvenuti, Laura; Fornai, Matteo; Di Salvo, Clelia; Natale, Gianfranco; Ryskalin, Larisa; Bertani, Lorenzo; Lucarini, Elena; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Nemeth, Zoltan H; Haskó, György; Antonioli, Luca | |
| Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue | 1-gen-2022 | Bertani, Lorenzo; Tricò, Domenico | |
| Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry | 1-gen-2022 | Tapete, Gherardo; Bertani, Lorenzo; Pieraccini, Alberto; Lynch, Erica Nicola; Giannotta, Martina; Morganti, Riccardo; Biviano, Ivano; Naldini, Sara; Mumolo, Maria Gloria; De Nigris, Francesca; Calella, Francesca; Bagnoli, Siro; Minciotti, Moira; Maltinti, Simona; Rentini, Silvia; Ceccarelli, Linda; Lionetti, Paolo; Milla, Monica; Costa, Francesco | |
| Intestinal histomorphological and molecular alterations in patients with Parkinson's disease | 1-gen-2022 | Bellini, G.; Benvenuti, L.; Ippolito, C.; Frosini, D.; Segnani, C.; Rettura, F.; Pancetti, A.; Bertani, L.; D'Antongiovanni, V.; Palermo, G.; Del Prete, E.; Antonioli, L.; Nardini, V.; Morganti, R.; Pellegrini, C.; Bernardini, N.; Ceravolo, R.; Fornai, M.; Bellini, M. | |
| Intestinal histomorphological and molecular alterations in patients with Parkinson's disease | 1-gen-2022 | Bellini, Gabriele; Benvenuti, Laura; Ippolito, Chiara; Frosini, Daniela; Segnani, Cristina; Rettura, Francesco; Pancetti, Andrea; Bertani, Lorenzo; D'Antongiovanni, Vanessa; Palermo, Giovanni; Del Prete, Eleonora; Antonioli, Luca; Nardini, Vincenzo; Morganti, Riccardo; Pellegrini, Carolina; Bernardini, Nunzia; Ceravolo, Roberto; Fornai, Matteo; Bellini, Massimo | |
| A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study | 1-gen-2021 | Barberio, B.; Cingolani, L.; Canova, C.; Barbieri, G.; Sablich, R.; Urbano, M. T.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Ferronato, A.; Buda, A.; Melatti, P.; Massimi, D.; Savarino, E. V.; Zingone, F. | |
| Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator | 1-gen-2021 | Cingolani, L.; Barberio, B.; Zingone, F.; Ferronato, A.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Melatti, P.; Gubbiotti, A.; Massimi, D.; Casadei, C.; D'Inca, R.; Savarino, E. V. | |
| Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) | 1-gen-2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M | |
| Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy | 1-gen-2021 | Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M | |
| Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults | 1-gen-2021 | Visaggi, P.; Savarino, E.; Sciume, G.; Chio, T. D.; Bronzini, F.; Tolone, S.; Frazzoni, M.; Pugno, C.; Ghisa, M.; Bertani, L.; Bellini, M.; Savarino, V.; Peroni, D.; Marchi, S.; de Bortoli, N. | |
| Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak | 1-gen-2021 | Bertani, Lorenzo; Barberio, Brigida; Tricò, Domenico; Zanzi, Federico; Maniero, Daria; Ceccarelli, Linda; Marsilio, Ilaria; Coppini, Francesca; Lorenzon, Greta; Mumolo, Maria Gloria; Zingone, Fabiana; Costa, Francesco; Savarino, Edoardo Vincenzo | |
| HOSPITALIZATION FOR DRUG INFUSION DOES NOT INCREASE COVID INFECTION RATE, IBD RELAPSES DUE TO INFECTIONS AND LEVELS OF ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY | 1-gen-2021 | Bertani, L; Barberio, B; Trico, D; Zanzi, F; Maniero, D; Ceccarelli, L; Marsilio, I; Minciotti, M; Coppini, F; Lorenzon, G; Mumolo, Mg; Zingone, F; Costa, F; Savarino, Ev | |
| Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers | 1-gen-2021 | Capecchi, R.; Migliorini, P.; Zanzi, F.; Maltinti, S.; Puxeddu, I.; de Bortoli, N.; Bellini, M.; Costa, F.; Marchi, S.; Bertani, L. | |
| Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis | 1-gen-2021 | Bertani, L.; Trico, D.; Zanzi, F.; Svizzero, G. B.; Coppini, F.; de Bortoli, N.; Bellini, M.; Antonioli, L.; Blandizzi, C.; Marchi, S. |